Emerald Health Therapeutics Canada Inc., a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations, is a wholly owned operating subsidiary of Emerald Health Therapeutics (EHT). EHT is publicly traded on the TSXV (EMH) and OTCQX (EMHTF). EHT is significantly expanding production capacity in anticipation of legal adult-use cannabis demand expected with Canadian federal legalization of recreational cannabis use in mid-2018. Emerald has extensive life science and medical expertise and is strongly focused on characterizing the potential medicinal attributes of cannabis and product innovation.
Emerald is focused on enhancing health through cannabis science!